ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
KEY POINTS: In this prespecified exploratory analysis of the AEGIS-II trial, the authors compare rates… Continue Reading
Featured NewsView All
KEY POINTS: In this prespecified exploratory analysis of the AEGIS-II trial, the authors compare rates… Continue Reading
KEY POINTS: In this exploratory analysis of the AEGIS-II randomized control trial, the authors compare… Continue Reading
Key Points: HFDetect-AI significantly improves the accuracy of diagnosing heart failure by predicting left ventricular… Continue Reading
Featured PodcastsView All
Dr. Fanikos Speaks at Brigham and Womens’ Hospital
Podcast: Download
NewsView All
Key Points: The PULSE-MI trial assessed the effects of pre-hospital pulse-dose glucocorticoid on final infarct… Continue Reading
Key Points: The 30-day ECLS SHOCK study demonstrated no benefit to up-front ECLS in the… Continue Reading
Key Points Drug-eluting stents are the standard of care for percutaneous coronary intervention of de… Continue Reading
Key Points: Familial chylomicronemia syndrome (FCS) is a clinically or genetically defined syndrome of extremely… Continue Reading
Key Points: Though primary PCI for coronary obstruction is first-line therapy in acute myocardial infarction… Continue Reading
Key Points: Factor XI inhibitors have the potential to reduce thromboembolic events while minimizing major… Continue Reading